Overview

Trial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the Knee

Status:
Terminated
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the effectiveness, safety and tolerability of lacosamide (LCM) 400mg/day in treating the signs and symptoms of osteoarthritis of the knee.
Phase:
Phase 2
Details
Lead Sponsor:
UCB Pharma
Treatments:
Lacosamide